Trial Profile
Does Dapagliflozin Augment The Favorable Adaptation To Endurance Exercise Training?
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 30 Jan 2018 Status changed from recruiting to completed.
- 10 Oct 2017 Planned End Date changed from 1 Jul 2017 to 1 Dec 2017.
- 10 Oct 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Dec 2017.